Hasil Pencarian - Hai-ping Dai
- Menampilkan 1 - 15 hasil dari 15
-
1
A Recurrent Cryptic MED14-HOXA9 Rearrangement in an Adult Patient With Mixed-Phenotype Acute Leukemia, T/myeloid, NOS oleh Qian Wang, Ling Zhang, Ming-qing Zhu, Zhao Zeng, Bao-zhi Fang, Jun-dan Xie, Jin-lan Pan, Chun-xiao Wu, Ni Wu, Ri Zhang, Su-ning Chen, Su-ning Chen, Hai-ping Dai, Hai-ping Dai
Diterbitkan 2021-07-01
Artikel -
2
Rapid Molecular Response to Dasatinib in a Pediatric Relapsed Acute Lymphoblastic Leukemia With NCOR1-LYN Fusion oleh Hai-Ping Dai, Hai-Ping Dai, Hai-Ping Dai, Jia Yin, Jia Yin, Jia Yin, Zheng Li, Zheng Li, Zheng Li, Chun-Xiao Yang, Tin Cao, Ping Chen, Yun-Hui Zong, Ming-Qing Zhu, Ming-Qing Zhu, Ming-Qing Zhu, Xia-Ming Zhu, Xia-Ming Zhu, Xia-Ming Zhu, Sheng Xiao, De-Pei Wu, De-Pei Wu, De-Pei Wu, Xiao-Wen Tang, Xiao-Wen Tang, Xiao-Wen Tang
Diterbitkan 2020-03-01
Artikel -
3
-
4
Efficacy of ruxolitinib in a patient with myelodysplastic/myeloproliferative neoplasm unclassifiable and co-mutated JAK2, SF3B1 and TP53 oleh Qian Wang, Hai-ping Dai, Dan-dan Liu, Jun-dan Xie, Hong Yao, Zi-xuan Ding, Ting-ting Tao, Su-ning Chen, Ri Zhang
Diterbitkan 2020-01-01
Artikel -
5
Patients with CML in the lymphoid blastic phase have inferior response to anti‐CD19 CAR T‐cell therapy compared to de novo Ph‐positive B cell acute lymphoblastic leukemia oleh Mei‐Jing Liu, Kai‐Wen Tan, Han‐Yu Cao, Si‐Man Huang, Chong‐Sheng Qian, Sheng‐Li Xue, Hai‐Ping Dai, Wen‐Jie Gong
Diterbitkan 2024-02-01
Artikel -
6
Case Report: Blinatumomab therapy for the treatment of B-cell acute lymphoblastic leukemia patients with central nervous system infiltration oleh Han-Yu Cao, Han-Yu Cao, Hui Chen, Song-Bai Liu, Wen-Jie Gong, Wen-Jie Gong, Chong-Sheng Qian, Chong-Sheng Qian, Tong-Tong Zhang, Tong-Tong Zhang, Chao-Ling Wan, Chao-Ling Wan, Si-Man Huang, Si-Man Huang, Nan Xu, Hai-Ping Dai, Hai-Ping Dai, Sheng-Li Xue, Sheng-Li Xue
Diterbitkan 2023-04-01
Artikel -
7
CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL oleh Hai-ping Dai, Dan-qing Kong, Hong-jie Shen, Wei Cui, Qian Wang, Zheng Li, Jia Yin, Li-qing Kang, Lei Yu, De-pei Wu, Xiao-wen Tang
Diterbitkan 2023-02-01
Artikel -
8
Haploidentical CD7 CAR T-cells induced remission in a patient with TP53 mutated relapsed and refractory early T-cell precursor lymphoblastic leukemia/lymphoma oleh Hai-ping Dai, Wei Cui, Qing-ya Cui, Wen-juan Zhu, Hui-min Meng, Min-qing Zhu, Xia-ming Zhu, Lin Yang, De-pei Wu, Xiao-wen Tang
Diterbitkan 2022-02-01
Artikel -
9
Identification of STRBP as a Novel JAK2 Fusion Partner Gene in a Young Adult With Philadelphia Chromosome-Like B-Lymphoblastic Leukemia oleh Xin-Yue Zhang, Xin-Yue Zhang, Hai-Ping Dai, Hai-Ping Dai, Zheng Li, Zheng Li, Jia Yin, Jia Yin, Xing-Ping Lang, Chun-Xiao Yang, Sheng Xiao, Ming-Qing Zhu, Ming-Qing Zhu, Dan-Dan Liu, Dan-Dan Liu, Hong Liu, Hong Liu, Hong-Jie Shen, Hong-Jie Shen, De-Pei Wu, De-Pei Wu, Xiao-Wen Tang, Xiao-Wen Tang
Diterbitkan 2021-01-01
Artikel -
10
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study oleh Yan-Yan Li, Shuai-Shuai Ge, Yuan-Hong Huang, Ming-Zhu Xu, Chao-Ling Wan, Kai-Wen Tan, Tao Tao, Hai-Xia Zhou, Sheng-Li Xue, Hai-Ping Dai
Diterbitkan 2024-01-01
Artikel -
11
Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph‐negative acute lymphoblastic leukemia relapsed post CD19 CART therapy oleh Si‐Man Huang, Chao‐Ling Wan, Han‐Yu Cao, Yan‐Yan Li, Chong‐Sheng Qian, Hai‐Xia Zhou, Ming‐Zhu Xu, Xiao‐Hui Hu, Lan Dai, Hai‐Ping Dai, Sheng‐Li Xue
Diterbitkan 2023-12-01
Artikel -
12
Efficacy and safety of decitabine combined with HAAG (homoharringtonine, aclarubicin, low-dose cytarabine and G-CSF) for newly diagnosed acute myeloid leukemia oleh Jun-Feng Zhu, Jun-Feng Zhu, Jun-Feng Zhu, Hai-Ping Dai, Hai-Ping Dai, Qian-Qian Zhang, Qian-Qian Zhang, Jia Yin, Jia Yin, Zheng Li, Zheng Li, Qin-Ya Cui, Qin-Ya Cui, Xiao-Peng Tian, Xiao-Peng Tian, Si-Ning Liu, Si-Ning Liu, Zheng-Ming Jin, Zheng-Ming Jin, Xia-Ming Zhu, Xia-Ming Zhu, De-Pei Wu, De-Pei Wu, Xiao-Wen Tang, Xiao-Wen Tang
Diterbitkan 2022-10-01
Artikel -
13
Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study oleh Miao Wang, Han-Yu Cao, Kai-Wen Tan, Qiao-Cheng Qiu, Yuan-Hong Huang, Shuai-shuai Ge, Zi-Hao Wang, Jia Chen, Xiao-Wen Tang, De-Pei Wu, Sheng-Li Xue, Zheng Li, Hai-Ping Dai
Diterbitkan 2023-11-01
Artikel -
14
Venetoclax with hypomethylating agents versus intensive chemotherapy in newly diagnosed acute myeloid leukemia with myelodysplasia related changes: A propensity score-matched analy... oleh Chao-Ling Wan, Yu-Qing Liu, Fang-Tong Liu, Yuan-Hong Huang, Han-Yu Cao, Si-Man Huang, Kai-Wen Tan, Shuai-Shuai Ge, Miao Wang, Mei-Jing Liu, Zi-Hao Wang, Zheng Li, Sheng-Li Xue, Hai-Ping Dai
Diterbitkan 2024-08-01
Artikel -
15
Multiomic single cell sequencing identifies stemlike nature of mixed phenotype acute leukemia oleh Cheryl A. C. Peretz, Vanessa E. Kennedy, Anushka Walia, Cyrille L. Delley, Andrew Koh, Elaine Tran, Iain C. Clark, Corey E. Hayford, Chris D’Amato, Yi Xue, Kristina M. Fontanez, Aaron A. May-Zhang, Trinity Smithers, Yigal Agam, Qian Wang, Hai-ping Dai, Ritu Roy, Aaron C. Logan, Alexander E. Perl, Adam Abate, Adam Olshen, Catherine C. Smith
Diterbitkan 2024-09-01
Artikel